miR-124 drug
Evidence from:
primary |
all sources
Related entities (8)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| miR-124 | expressed_in | central nervous system | — | 1 |
| miR-124 | regulates | induced neurons | — | 2 |
| miR-124 | regulates | MAP2 | — | 1 |
| miR-124 | regulates | NEUROD1 | — | 1 |
| miR-124 | regulates | neuronal fate | — | 1 |
| miR-124 | regulates | Ngn2 | — | 1 |
| NEUROD2 | interacts_with | miR-124 | — | 1 |
| Rest | regulates | miR-124 | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Neuroepigenetics and addiction. (2018)
- Prenatal arsenic exposure alters REST/NRSF and microRNA regulators of embryonic neural stem cell fate in a sex-dependent manner. (2017)
- Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells. (2016)
- The role of BAF (mSWI/SNF) complexes in mammalian neural development. (2014)
- Induced neuronal reprogramming. (2014)
- Epigenetics, microRNA, and addiction. (2014)
- Suppression and epigenetic regulation of MiR-9 contributes to ethanol teratology: evidence from zebrafish and murine fetal neural stem cell models. (2013)
- Emerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders. (2012)
- Transcriptional and epigenetic mechanisms of addiction. (2011)
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. (2010)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| mir-124 | gene | 8 | 21 |
| mir-124 | drug | 6 | 11 |
| microrna-124 | drug | — | — |